Mastering Biopharmaceutical Characterization
Mass spectrometry continues to develop as a pivotal technique to ensure the safety and efficacy of the most advanced biotherapeutics and vaccines. In this session, you'll gain valuable insights into the characterization and quantification of complex biomolecules, and explore the role of high-resolution LC-MS in drug discovery, development, manufacturing and quality control. Discover how recent advancements in multi-reflecting time-of-flight mass spectrometry is shaping the future of biologics and deepening our understanding of these vital therapeutics.
Who Should Attend:
- Learn about the operation of the novel Xevo MRT MS technology and see it in Action!
- Discover how we unravel the complexity of peptide mapping workflows—including sequence mapping and host cell protein (HCP) analysis
- Determine how multi-reflecting time-of-flight technology delivers quantitative and qualitative performance at fast acquisition speeds for biopharmaceutical workflows including oligonucleotide analysis
The session will conclude with a live Q&A where members of the Waters Xevo MRT team will be on hand to answer all of your questions.
Presenter: Jonathan Fox (Principal Applications Chemist, Waters Corporation)
Jon Fox is a principal applications chemist in the European Applications Laboratory team based in Wilmslow, UK. Jon joined Waters in December 2000, following on from his degree in drug design and toxicology, With over 20 years mass spectrometry experience supporting customers in the field with training, developing and troubleshoot their applications, now currently developing strategy, solutions and demonstrations in the European applications lab . His areas of expertise in include ion mobility, high resolution MS for analysis of oligonucleotides, proteomics, DMPK, APGC Food & Environment and metabolomics.
